Epstein – Barr virus infection is not the sole cause of high prevalence for Hodgkin's lymphoma in Saudi Arabia

References

• Mueller N E, Mohar A, Evans A. Viruses other than HIV and non-Hodgkin's lymphoma. Cancer Res 1992; 1(Suppl)5479s–5481s
   Google Scholar
• Engel M, Essop M F, Close P, Hartley P, Pallesen G, Sinclair-Smith C. Improved prognosis of Epstein-Barr virus associated childhood Hodgkin's lymphoma: study of 47 South African cases. J Clin Pathol 2000; 53: 182–186
   PubMed Web of Science ®Google Scholar
• Bazarbashi S, De Vol E, Young S, Al-Eid H, Arteh S. Cancer Incidence Report Saudi Arabia 1999-2000. National Cancer Registry May, 2004
   Google Scholar
• Ezzat A, Al-Rajhi N, Te O, Qahtani F, Alsaad R, Sarginson H. 2001 Tumor Registry Annual Report. KFSHRC Department of Oncology Annual Report December, 2002
   Google Scholar
• Morente M M, Piris M A, Abraira V, Acevedo A, Aguilera B, Bellas C, et al. Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression. Blood 1997; 90: 2429–2436
   PubMed Web of Science ®Google Scholar
• Martinez-Valdez H, Guret C, de Bouteiller O, Fugier I, Banchereau J, Liu Y J. Human germinal center B cells express the apoptosis-inducing genes Fas, c-myc, P53, and Bax but not the survival gene bcl-2. J Exp Med 1996; 183: 971–977
   PubMed Web of Science ®Google Scholar
• Anagnostopoulos I, Herbst H, Niedobitek G, Stein H. Demonstration of monoclonal EBV genomes in Hodgkin's disease and Ki-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 1989; 74: 810–816
   PubMed Web of Science ®Google Scholar
• Weiss L M, Movahed L A, Warnke R A, Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 1989; 320: 502–506
   PubMed Web of Science ®Google Scholar
• Wu T C, Mann R B, Charache P, Hayward S D, Staal S, Lambe B C, et al. Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease. Int J Cancer 1990; 46: 801–804
   PubMed Web of Science ®Google Scholar
• Rao C, Bhatia K. Frequency of EBV Association and P53 Expression in Childhood and Adult Hodgkin's Disease in India. Int J Ped Hem/Onc 1999; 60: 1–10
   Google Scholar
• Zhou X G, Sandvej K, Li P J, Ji X L, Yan Q H, Zhang X P, et al. Epstein – Barr virus gene polymorphisms in Chinese Hodgkin's disease cases and healthy donors: identification of three distinct virus variants. J Gen Virol 2001; 82(Pt 5)1157–1167
   PubMed Web of Science ®Google Scholar
• Ambinder R F, Browning P J, Lorenzana I, Leventhal B G, Cosenza H, Mann R B, et al. Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood 1993; 81: 462–467
   PubMed Web of Science ®Google Scholar
• Armstrong A A, Alexander F E, Paes R P, Morad N A, Gallagher A, Krajewski A S, Jones D B, Angus B, Adams J, Cartwright R A, et al. Association of Epstein-Barr virus with pediatric Hodgkin's disease. Am J Pathol 1993; 142: 1683–1688
   PubMed Web of Science ®Google Scholar
• Chang K L, Albujar P F, Chen Y Y, Johnson R M, Weiss L M. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru. Blood 1993; 81: 496–501
   PubMed Web of Science ®Google Scholar
• Glaser S L, Lin R J, Stewart S L, Ambinder R F, Jarrett R F, Brousset P, et al. Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data. Int J Cancer 1997; 70: 375–382
   PubMed Web of Science ®Google Scholar
• Leoncini L, Spina D, Nyong'o A, Abinya O, Minacci C, Disanto A, et al. Neoplastic cells of Hodgkin's disease show differences in EBV expression between Kenya and Italy. Int J Cancer 1996; 65: 781–784
   PubMed Web of Science ®Google Scholar
• Preciado M V, De Matteo E, Diez B, Menarguez J, Grinstein S. Presence of Epstein-Barr virus and strain type assignment in Argentine childhood Hodgkin's disease. Blood 1995; 86: 3922–3929
   PubMed Web of Science ®Google Scholar
• Quintanilla-Martinez L, Gamboa-Domnquez A, Gamez-Ledesma I, Angeles-Angeles A, Mohar A. Association of Epstein-Barr virus latent membrane protein and Hodgkin's disease in Mexico. Mod Pathol 1995; 8: 675–679
   PubMed Web of Science ®Google Scholar
• Weinreb M, Day P J, Niggli F, Green E K, Nyong'o A O, Othieno-Abinya N A, et al. The consistent association between Epstein-Barr virus and Hodgkin's disease in children in Kenya. Blood 1996; 87: 3828–3836
   PubMed Web of Science ®Google Scholar
• Weinreb M, Day P J, Niggli F, Powell J E, Raafat F, Hesseling P B, et al. The role of Epstein-Barr virus in Hodgkin's disease from different geographical areas. Arch Dis Child 1996; 74: 27–31
   PubMed Web of Science ®Google Scholar
• Chan J K, Yip T T, Tsang W Y, Lau W H, Wong C S, Ma V W. Detection of Epstein-Barr virus in Hodgkin's disease occurring in an Oriental population. Hum Pathol 1995; 26: 314–318
   PubMed Web of Science ®Google Scholar
• Zhou X G, Hamilton-Dutoit S J, Yan Q H, Pallesen G. The association between Epstein-Barr virus and Chinese Hodgkin's disease. Int J Cancer 1993; 55: 359–363
   PubMed Web of Science ®Google Scholar
• Mack T M, Cozen W, Shibata D K, Weiss L M, Nathwani B N, Hernandez A M, et al. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease. N Engl J Med 1995; 332: 413–418
   PubMed Web of Science ®Google Scholar
• Muschen M, Re D, Brauninger A, Wolf J, Hansmann M L, Diehl V, Kuppers R, Rajewsky K. Somatic mutations of the CD95 gene in Hodgkin and Reed-Sternberg cells. Cancer Res 2000; 60: 5640–5643
   PubMed Web of Science ®Google Scholar
• Maggio E M, Van Den Berg A, de Jong D, Diepstra A, Poppema S. Low frequency of FAS mutations in Reed-Sternberg cells of Hodgkin's lymphoma. Am J Pathol 2003; 162: 29–35
   PubMed Web of Science ®Google Scholar
• Emmerich F, Meiser M, Hummel M, Demel G, Foss H D, Jundt F, et al. Overexpression of I kappa B alpha without inhibition of NF-kappa B activity and mutations in the I kappa B alpha gene in Reed-Sternberg cells. Blood 1999; 94: 3129–3134
   PubMed Web of Science ®Google Scholar
• Cabannes E, Khan G, Aillet F, Jarrett R F, Hay R T. Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha. Oncogene 1999; 18: 3063–3070
   PubMed Web of Science ®Google Scholar
• Jungnickel B, Staratschek-Jox A, Brauninger A, Spieker T, Wolf J, Diehl V, et al. Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma. J Exp Med 2000; 191: 395–402
   PubMed Web of Science ®Google Scholar
• Joos S, Kupper M, Ohl S, von Bonin F, Mechtersheimer G, Bentz M, et al. Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30 + Hodgkin cells. Cancer Res 2000; 60: 549–552
   PubMed Web of Science ®Google Scholar
• Joos S, Menz C K, Wrobel G, Siebert R, Gesk S, Ohl S, et al. Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2. Blood 2002; 99: 1381–1387
   PubMed Web of Science ®Google Scholar
• Nocito A, Kononen J, Kallioniemi O P, Sauter G. Tissue microarrays (TMAs) for high-throughput molecular pathology research. Int J Cancer 2001; 94: 1–5
   PubMed Web of Science ®Google Scholar
• Liu S M, Chow K C, Chiu C F, Tzeng C H. Expression of Epstein-Barr virus in patients with Hodgkin's disease in Taiwan. Cancer 1998; 83: 367–371
   PubMed Web of Science ®Google Scholar
• Jaffe E S, Harris N L, Stein H, Vardiman J W. Tumors of haematopoietic and lymphoid tissues. IARC Press, Lyon 2001; 175–176
   Google Scholar
• Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998; 4: 844–847
   PubMed Web of Science ®Google Scholar
• Natkunam Y, Warnke R A, Montgomery K, Falini B, van De Rijn M. Analysis of MUM1/IRF4 protein expression using tissue microarrays and immunohistochemistry. Mod Pathol 2001; 14: 686–694
   PubMed Web of Science ®Google Scholar
• Hedvat C V, Hegde A, Chaganti R S, Chen B, Qin J, Filippa D A, et al. Application of tissue microarray technology to the study of non-Hodgkin's and Hodgkin's lymphoma. Hum Pathol 2002; 33: 968–974
   PubMed Web of Science ®Google Scholar
• Milanes-Yearsley M, Hammond M E, Pajak T F, Cooper J S, Chang C, Griffin T, et al. Tissue micro-array: a cost and time-effective method for correlative studies by regional and national cancer study groups. Mod Pathol 2002; 15: 1366–1373
   PubMed Web of Science ®Google Scholar
• Jarrett A F, Armstrong A A, Alexander E. Epidemiology of EBV and Hodgkin's lymphoma. Ann Oncol 1996; 7(Suppl)5–10
   PubMed Web of Science ®Google Scholar
• Huh J, Park C, Juhng S, Kim C E, Poppema S, Kim C. A pathologic study of Hodgkin's disease in Korea and its association with Epstein-Barr virus infection. Cancer 1996; 77: 949–955
   PubMed Web of Science ®Google Scholar
• Zarate-Osorno A, Roman L N, Kingma D W, Meneses-Garcia A, Jaffe E S. Hodgkin's disease in Mexico. Prevalence of Epstein-Barr virus sequences and correlations with histologic subtype. Cancer 1995; 75: 1360–1366
   PubMed Web of Science ®Google Scholar
• Jarrett R F, Gallagher A, Jones D B, Alexander F E, Krajewski A S, Kelsey A, et al. Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age. J Clin Pathol 1991; 44: 844–848
   PubMed Web of Science ®Google Scholar
• Gulley M L, Eagan P A, Quintanilla-Martinez L, Picado A L, Smir B N, Childs C, et al. Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: association with mixed cellularity subtype and Hispanic American ethnicity. Blood 1994; 83: 1595–1602
   PubMed Web of Science ®Google Scholar
• Medeiros L J, Greiner T C. Hodgkin's disease. Cancer 1995; 75(Suppl)357–369
   PubMed Web of Science ®Google Scholar
• Axdorph U, Porwit-MacDonald A, Sjoberg J, Grimfors G, Ekman M, Wang W, et al. Epstein-Barr virus expression in Hodgkin's disease in relation to patient characteristics, serum factors and blood lymphocyte function. Br J Cancer 1999; 81: 1182–1187
   PubMed Web of Science ®Google Scholar
• Flavell K J, Billingham L J, Biddulph J P, Gray L, Flavell J R, Constandinou C M, et al. The effect of Epstein-Barr virus status on outcome in age- and sex-defined subgroups of patients with advanced Hodgkin's disease. Ann Oncol 2003; 14: 282–290
   PubMed Web of Science ®Google Scholar
• Naresh K N, Johnson J, Srinivas V, Soman C S, Saikia T, Advani S H, et al. Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells. Ann Oncol 2000; 11: 91–96
   PubMed Web of Science ®Google Scholar
• Murray P G, Billingham L J, Hassan H T, Flavell J R, Nelson P N, Scott K, et al. Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease. Blood 1999; 94: 442–447
   PubMed Web of Science ®Google Scholar
• Clarke C A, Glaser S L, Dorfman R F, Mann R, DiGiuseppe J A, Prehn A W, Ambinder R F. Epstein-Barr virus and survival after Hodgkin disease in a population-based series of women. Cancer 2001; 91: 1579–1587
   PubMed Web of Science ®Google Scholar